These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3730582)

  • 21. Protamine inhibits platelet derived growth factor receptor activity but not epidermal growth factor activity.
    Huang JS; Nishimura J; Huang SS; Deuel TF
    J Cell Biochem; 1984; 26(4):205-20. PubMed ID: 6099364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of anti-hyperglycemic activity of some novel monocyclic beta lactams.
    Goel RK; Mahajan MP; Kulkarni SK
    J Pharm Pharm Sci; 2004 Apr; 7(1):80-3. PubMed ID: 15144739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Action of heparin and protamine sulfate on serum complement activity and on rejection phenomenon in experimental skin heterotransplants].
    Di Perri T; Grossi A; Auteri A; Carli A; Rocco F
    Boll Soc Ital Biol Sper; 1969 Aug; 45(16):1083-5. PubMed ID: 4911886
    [No Abstract]   [Full Text] [Related]  

  • 24. [Relaxant effects of protamine sulfate on isolated renal arteries of normotensive and hypertensive rats].
    Oresscanin Z; Milovanović SR; Spasić M
    Med Pregl; 2003; 56 Suppl 1():53-7. PubMed ID: 15510915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protamine-heparin membrane for cell microencapsulation.
    Tatarkiewicz K; Sitarek E; Fiedor P; Sabat M; Orlowski T
    Transplant Proc; 1994 Dec; 26(6):3509. PubMed ID: 7998252
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of recombinant platelet factor 4 and protamine sulfate for heparin neutralization: clotting and clearance studies in rat.
    Korutla LN; Stewart GJ; Lasz EC; Maione TE; Niewiarowski S
    Thromb Haemost; 1994 May; 71(5):609-14. PubMed ID: 8091389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversal of protamine of the prolonged response to intrapulmonary heparin.
    Wright CJ; Mahadoo J; Jaques LB
    Can J Surg; 1981 Mar; 24(2):130-2. PubMed ID: 7225967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prophylactic effect of vitamin A, neutralizing the development of experimental insulin-dependent diabetes in animals].
    Kudriashov BA; Ul'ianov AM; Tarasov IuA
    Vopr Med Khim; 1993; 39(1):20-2. PubMed ID: 8498064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Action of heparin and protamine sulfate administration on serum complement levels in man].
    Di Perri T; Auteri A
    Boll Soc Ital Biol Sper; 1970 Oct; 46(20):817-9. PubMed ID: 5519564
    [No Abstract]   [Full Text] [Related]  

  • 30. Successful rat-to-mouse xenotransplantation of Langerhans islets microencapsulated within a protamine-heparin membrane.
    Tatarkiewicz K; Sitarek E; Fiedor P; Sabat M; Morzycka-Michalik M; Orlowski T
    Transplant Proc; 1994 Apr; 26(2):807-8. PubMed ID: 8171670
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of heparin, protamine sulfate and pantrypin on the carbohydrate metabolism and noradrenaline content of the vascular wall].
    Smirnov PA
    Farmakol Toksikol; 1972; 35(2):225-8. PubMed ID: 5021662
    [No Abstract]   [Full Text] [Related]  

  • 32. [Role of the pancreas in the appearance of the diabetogenic factor during the development of alloxan diabetes].
    Kudriashov BA; Tarasov IuA; Ul'ianov AM
    Patol Fiziol Eksp Ter; 1989; (3):75-9. PubMed ID: 2797907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction in the diabetogenic effect of alloxan in mice by treatment with the antineoplastic agent ICRF-187.
    El-Hage AN; Herman EH; Ferrans VJ
    Res Commun Chem Pathol Pharmacol; 1981 Sep; 33(3):509-23. PubMed ID: 7036302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of heparin with basic fibroblast growth factor, epidermal growth factor, and constitutive nitric oxide synthase on healing of gastric ulcer in rats.
    Li Y; Wang HY; Cho CH
    J Pharmacol Exp Ther; 1999 Aug; 290(2):789-96. PubMed ID: 10411593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of chlorpropamide on the sensitivity of rats to the diabetogenic action of alloxan].
    Tikhonova NE
    Probl Endokrinol (Mosk); 1970; 16(2):95-9. PubMed ID: 5441679
    [No Abstract]   [Full Text] [Related]  

  • 36. [Experimental study of the heparin antagonist protamine chloride].
    Efimov VS
    Farmakol Toksikol; 1968; 31(5):601-4. PubMed ID: 5707736
    [No Abstract]   [Full Text] [Related]  

  • 37. [Action of heparin and protamine sulfate on the level of hematic complement evaluated with the immuno-hemolysis method. Studies in vivo].
    Di Perri T; Grossi A; Auteri A; Rocco F
    Boll Soc Ital Biol Sper; 1969 May; 45(10):677-9. PubMed ID: 5399985
    [No Abstract]   [Full Text] [Related]  

  • 38. Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man.
    Wolzt M; Weltermann A; Nieszpaur-Los M; Schneider B; Fassolt A; Lechner K; Eichler HG; Kyrle PA
    Thromb Haemost; 1995 Mar; 73(3):439-43. PubMed ID: 7667826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of alloxan diabetes, insulin & diabetogenic hormones on intestinal transport of tyrosine in rats.
    Mahmood A; Siddiqi M
    Indian J Exp Biol; 1972 May; 10(3):237-9. PubMed ID: 4346754
    [No Abstract]   [Full Text] [Related]  

  • 40. [Animal sensitivity to the diabetogenic action of alloxan during cold adaptation].
    Shorin IuP; Seliatitskaia VG; Nepomniashchikh GI; Pal'chikova NA; Khodova RR
    Biull Eksp Biol Med; 1984 Aug; 98(8):240-2. PubMed ID: 6466864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.